Change in blood-brain barrier permeability during pediatric diabetic ketoacidosis treatment

Pediatric Critical Care Medicine

Volumn 11, Issue 3, 2010, Pages 332-338

  Vavilala, Monica S ^a,c,d   Richards, Todd L ^b   Roberts, Joan S ^d   Chiu, Harvey ^c,d   Pihoker, Catherine ^c,d   Bradford, Heidi ^c,d   Deeter, Kristina ^c,d   Marro, Ken I ^b   Shaw, Dennis ^d  

^a Dept Anesth Critical Care Med J   (United States)

^b and Pediatrics   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d SEATTLE CHILDREN S HOSPITAL   (United States)

Author keywords

blood brain barrier; diabetic ketoacidosis; permeability

Indexed keywords

BICARBONATE; GLUCOSE; INSULIN;

ADOLESCENT; ARTICLE; BASAL GANGLION; BLOOD BRAIN BARRIER; BRAIN EDEMA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; FEMALE; FRONTAL CORTEX; HUMAN; MALE; OBSERVATIONAL STUDY; OCCIPITAL CORTEX; PEDIATRIC HOSPITAL; PERMEABILITY BARRIER; PH; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADOLESCENT; BLOOD-BRAIN BARRIER; BRAIN; BRAIN EDEMA; CHILD; DIABETIC KETOACIDOSIS; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; PERMEABILITY; PROSPECTIVE STUDIES;

EID: 77952310940     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3181c013f4     Document Type: Article

References (32)

1. Rewers A, Klingensmith G, Davis C, et al: Presence of diabetic ketoacidosis at diagnosis of diabetes mellitus in youth: the Search for Diabetes in Youth Study. Pediatrics 2008; 121:e1258-e1266
2. Rewers A, Chase HP, Mackenzie T, et al: Predictors of acute complications in children with type 1 diabetes. JAMA 2002; 287:2511-2518
3. Hanas R, Lindblad B, Lindgren F: Diabetic ketoacidosis and cerebral edema in Sweden, a 2-year population study. Abstr. Diabetes 2004; 53(Suppl 2):A421
4. Roche EF, Menon A, Gill D, et al: Clinical presentation of type 1 diabetes. Pediatr Diabetes 2005; 6:75-78
5. Edge JA: Cerebral oedema during treatment of diabetic ketoacidosis: Are we any nearer finding a cause? Diabetes Metab Res Rev 2000; 16:316-324
6. Glaser NS, Barnett P, McCaslin I, et al: Risk factors for cerebral edema in children with diabetic ketoacidosis. N Engl J Med 2001; 344:264-269
7. Roberts JS, Vavilala MS, Schenkman KA, et al: Cerebral hyperemia and impaired cerebral autoregulation associated with diabetic ketoacidosis in critically ill children. Crit Care Med 2006; 34:2258-2259
8. Glaser NS, Wootton-Gorges SL, Marcin JP, et al: Mechanism of cerebral edema in children with diabetic ketoacidosis. J Pediatr 2004; 145:164-171
9. Dietrich WD: Inflammatory factors regulating the blood-brain barrier. In: Inflammatory cells and mediators in CNS disease. Feuerstein GZ (Ed). Amsterdam, Harwood Academic, 1999, pp 137-155
10. Jenkinson M, Bannister P, Brady M, et al: Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neruoimage 2002; 17:825-841
11. Smith S: Fast Robust Automated Brain Extraction. Human Brain Mapping 2002; 17:143-155
12. Demsar F, Roberts TP, Schwickert HC, et al: A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution. Magn Reson Med 1997; 37:236-242
13. Ivanusa T, Katarina B, Medic J, et al: Dynamic contrast enhanced MRI of mouse fibrosarcoma using small-molecular and novel macromolecular contrast agents. Physica Medica 2007; 23:85-90
14. Larsson HB, Tofts PS: Measurement of blood-brain barrier permeability using dynamic Gd-DTPA scanning-A comparison of methods. Magn Reson Med 1992; 24:174-176
15. Aviv RI, d’Esterre CD, Murphy BD, et al: Hemorrhagic transformation of ischemic stroke: Prediction with CT perfusion. Radiology 2009; 250:867-877
16. Qiao ZW, Xia CM, Zhu YB, et al: First-pass perfusion computed tomography: Initial experience in differentiating adrenal adenoma from metastasis. Eur J Radiol 2009 Feb 4 [Epub ahead of print]
17. Zaharchuk G: Theoretical basis of hemodynamic MR imaging techniques to measure cerebral blood volume, cerebral blood flow, and permeability. AJNR Am J Neuroradiol 2007; 28:1850-1858
18. Law M, Yang S, Babb JS, et al: Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 2004; 25:746-755
19. Hawkins BT, Lundeen TF, Norwood KM, et al: Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: Contribution of hyperglycaemia and matrix metalloproteinases. Diabetologia 2007; 50:202-211
20. Banks WA, Jaspan JB, Kastin AJ: Effect of diabetes mellitus on the permeability of the blood-brain barrier to insulin. Peptides 1997; 18:1577-1584
21. Badaut J, Brunet JF, Regli L: Aquaporins in the brain: From aqueduct to ‘multi-duct.’ Metab Brain Dis 2007; 22:251-263
22. Badaut J, Lasbennes F, Magistretti PJ, et al: Aquaporins in brain: Distribution, physiology, and pathophysiology. J Cereb Blood Flow Metab 2002; 22:367-378
23. Arieff AI, Dorener T, Zelig H, et al: Mechanisms of seizures and coma in hypoglycemia. Evidence for direct effect of insulin on electrolyte transport in brain. J Clin Invest 1974; 54:654-663
24. Mooradian AD, Haas MJ, Batejko O, et al: Statins ameliorate endothelial barrier permeability changes in the cerebral tissue of streptozotocin-induced diabetic rats. Diabetes 2005; 54:2977-2982
25. Stroemer RP, Rothwell NJ: Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1beta in the rat. J Cereb Blood Flow Metab 1998; 18:833-839
26. Blamire AM, Anthony DC, Rajagopalan B, et al: Interleukin-1beta-induced changes in blood-brain barrier permeability, apparent diffusion coefficient, and cerebral blood volume in the rat brain: A magnetic resonance study. J Neurosci 2000; 20:8153-8159
27. Kubaszek A, Pihlajamäki J, Punnonen K, et al: The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity. Diabetes 2003; 52:558-561
28. Cooper JD, Smyth DJ, Bailey R, et al: The candidate genes TAF5L, TCF7, PDCD1, IL6 and ICAM1 cannot be excluded from having effects in type 1 diabetes. BMC Med Genet 2007; 8:71
29. Hoffman WH, Burek CL, Waller JL, et al: Cytokine response to diabetic ketoacidosis and its treatment. Clin Immunol 2003; 108:175-181
30. Lin JJ, Lin KL, Wang HS, et al: Occult infarct with acute hemorrhagic stroke in juvenile diabetic ketoacidosis. Brain Dev 2008; 30:91-93
31. Winkler T, Sharma HS, Stalberg E, et al: Impairment of blood-brain barrier function by serotonin induces desynchronization of spontaneous cerebral cortical activity: Experimental observations in the anaesthetized rat. Neuroscience 1995; 68:1097-1104
32. Huber JD, VanGilder RL, Houser KA: Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats. Am J Physiol Heart Circ Physiol 2006; 291:H2660-H2668